Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Aurinia Pharmaceuticals Inc. publishes a filing, an earnings call transcript or a press release.

Get AUPH alerts

About Stephen Robertson

Stephen Robertson is recorded as General Counsel at Aurinia Pharmaceuticals Inc. (AUPH). The newest filing on record that lists Stephen Robertson as General Counsel at Aurinia Pharmaceuticals Inc. (AUPH) is dated April 17, 2025. The proxy statement of Aurinia Pharmaceuticals Inc. reports total compensation of $2,126,510 for Stephen Robertson in fiscal 2025, including a base salary of $481,900. Disclosed compensation is on record for 8 fiscal years. Aurinia Pharmaceuticals Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Aurinia Pharmaceuticals Inc. includes Jeffrey Bailey (CEO and Board Member), Kevin Tang (CEO and Board Member), Peter Greenleaf (CEO and Board Member) and 7 others.

Affiliation history

Company network

Leadership on record at Aurinia Pharmaceuticals Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Aurinia Pharmaceuticals Inc. (AUPH) $481,900 $2,126,510
2024 Aurinia Pharmaceuticals Inc. (AUPH) $471,702 $2,216,429
2023 Aurinia Pharmaceuticals Inc. (AUPH) $478,727 $3,598,254
2022 Aurinia Pharmaceuticals Inc. (AUPH) $458,696 $3,240,355
2021 Aurinia Pharmaceuticals Inc. (AUPH) $448,373 $722,690
2020 Aurinia Pharmaceuticals Inc. (AUPH) $73,752 $3,566,863
2019 Aurinia Pharmaceuticals Inc. (AUPH) — —
2018 Aurinia Pharmaceuticals Inc. (AUPH) — —

Recent activity

No call appearances or filed executive changes recorded yet.